Kathryn Starzyk

463 total citations
15 papers, 315 citations indexed

About

Kathryn Starzyk is a scholar working on Epidemiology, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kathryn Starzyk has authored 15 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Obstetrics and Gynecology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kathryn Starzyk's work include Pregnancy and preeclampsia studies (4 papers), Influenza Virus Research Studies (2 papers) and Respiratory viral infections research (2 papers). Kathryn Starzyk is often cited by papers focused on Pregnancy and preeclampsia studies (4 papers), Influenza Virus Research Studies (2 papers) and Respiratory viral infections research (2 papers). Kathryn Starzyk collaborates with scholars based in United States, United Kingdom and Switzerland. Kathryn Starzyk's co-authors include John Yee, Sharon E. Smith, Susan Richards, Nancy A Dreyer, Robert Pijnenborg, Paul K.S. Chan, Ahmet Faik Öner, Nelson Lee, Viktor Gasimov and Nazım Doğan and has published in prestigious journals such as Gastroenterology, Neurology and The Journal of Infectious Diseases.

In The Last Decade

Kathryn Starzyk

14 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Starzyk United States 6 146 88 51 48 44 15 315
Jinfeng Liu China 14 344 2.4× 48 0.5× 8 0.2× 71 1.5× 43 1.0× 58 572
Madeleine R. Heldman United States 11 87 0.6× 20 0.2× 19 0.4× 69 1.4× 14 0.3× 33 354
Jianhui Fan China 11 80 0.5× 36 0.4× 127 2.5× 44 0.9× 159 3.6× 23 446
Kevin Inchley Canada 12 58 0.4× 50 0.6× 18 0.4× 14 0.3× 104 2.4× 13 615
Nadia Ben Fredj Tunisia 13 90 0.6× 21 0.2× 9 0.2× 65 1.4× 103 2.3× 60 479
Abha Sharma India 9 176 1.2× 15 0.2× 28 0.5× 33 0.7× 11 0.3× 34 413
Pratibha Singh United States 11 83 0.6× 32 0.4× 10 0.2× 16 0.3× 77 1.8× 26 372
Tanju Özkan Türkiye 11 165 1.1× 33 0.4× 6 0.1× 41 0.9× 40 0.9× 29 372
Guijin Zhu China 17 73 0.5× 31 0.4× 151 3.0× 14 0.3× 292 6.6× 54 1.2k
Yixiang Zheng China 13 159 1.1× 21 0.2× 10 0.2× 75 1.6× 60 1.4× 24 500

Countries citing papers authored by Kathryn Starzyk

Since Specialization
Citations

This map shows the geographic impact of Kathryn Starzyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Starzyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Starzyk more than expected).

Fields of papers citing papers by Kathryn Starzyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Starzyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Starzyk. The network helps show where Kathryn Starzyk may publish in the future.

Co-authorship network of co-authors of Kathryn Starzyk

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Starzyk. A scholar is included among the top collaborators of Kathryn Starzyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Starzyk. Kathryn Starzyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Imel, Erik A., Kathryn Starzyk, Richard E Gliklich, et al.. (2020). Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis. Osteoporosis International. 31(12). 2413–2424. 1 indexed citations
2.
Leavy, Michelle B, Kathryn Starzyk, Evan R. Myers, Gary C. Curhan, & Richard E Gliklich. (2020). Usingreal‐worldevidence to support a changing paradigm for cancer screening: A commentary. Pharmacoepidemiology and Drug Safety. 29(10). 1312–1315.
3.
4.
5.
Engel, Pierre, et al.. (2016). Lessons learned on the design and the conduct of Post‐Authorization Safety Studies: review of 3 years of PRAC oversight. British Journal of Clinical Pharmacology. 83(4). 884–893. 32 indexed citations
6.
Rath, Barbara, et al.. (2014). A prospective observational study of oseltamivir safety and tolerability in infants and young children ≤24 months. Pharmacoepidemiology and Drug Safety. 24(3). 286–296. 9 indexed citations
7.
Butzkueven, Helmut, Sonia Hernández–Dı́az, Gideon Koren, et al.. (2013). Multinational Gilenya (TM) (Fingolimod) Pregnancy Exposure Registry: Preliminary Results. 80. 4 indexed citations
8.
Geissbühler, Yvonne, Helmut Butzkueven, Sonia Hernández–Dı́az, et al.. (2013). Multinational Gilenya™ (Fingolimod) Pregnancy Exposure Registry: Preliminary Results (P02.134). Neurology. 80(7_supplement). 2 indexed citations
9.
Geissbühler, Yvonne, Helmut Butzkueven, Sonia Hernández–Dı́az, et al.. (2012). Multinational Gilenya  (Fingolimod) Pregnancy Exposure Registry in Multiple Sclerosis: Study Design (P06.189). Neurology. 78(Meeting Abstracts 1). P06.189–P06.189. 2 indexed citations
10.
Adisasmito, Wiku, Paul K.S. Chan, Nelson Lee, et al.. (2010). Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient Registry. The Journal of Infectious Diseases. 202(8). 1154–1160. 111 indexed citations
11.
Starzyk, Kathryn, et al.. (2006). The long-term international safety experience of imiglucerase therapy for Gaucher disease. Molecular Genetics and Metabolism. 90(2). 157–163. 92 indexed citations
12.
Starzyk, Kathryn, Robert Pijnenborg, & Carolyn Salafia. (1999). Decidual and Vascular Pathophysiology in Pregnancy Compromise. Seminars in Reproductive Medicine. 17(1). 63–72. 12 indexed citations
13.
Salafia, Carolyn M., Kathryn Starzyk, Janice M. Lage, et al.. (1998). Lipoprotein(a) deposition in the uteroplacental bed and in basal plate uteroplacental arteries in normal and complicated pregnancies. Placenta. 19. 377–387. 4 indexed citations
14.
Starzyk, Kathryn, Carolyn M. Salafia, John C. Pezzullo, et al.. (1997). Quantitative differences in arterial morphometry define the placental bed in preeclampsia. Human Pathology. 28(3). 353–358. 42 indexed citations
15.
Salafia, C.M., Kathryn Starzyk, John C. Pezzullo, et al.. (1996). Quantitative differences in arterial morphometry define the placental bed in preeclampsia. Placenta. 17(5-6). A19–A19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinfeng Liu Breakdown of academic impact, for papers by Madeleine R. Heldman Breakdown of academic impact, for papers by Jianhui Fan Breakdown of academic impact, for papers by Kevin Inchley Breakdown of academic impact, for papers by Nadia Ben Fredj Breakdown of academic impact, for papers by Abha Sharma Breakdown of academic impact, for papers by Pratibha Singh Breakdown of academic impact, for papers by Tanju Özkan Breakdown of academic impact, for papers by Guijin Zhu Breakdown of academic impact, for papers by Yixiang Zheng
Rankless by CCL
2026